Transitional cell carcinoma (TCC) is the second many common urologic malignancy and 70% of individuals present with superficial or nonmuscle intrusive bladder cancer (NMIBC). chemotherapeutic regimens using hyperthermia photodynamic therapy magnetically-targeted companies and liposomes continues to be a location of energetic analysis. Despite enthusiasm for new intravesical agents radical cystectomy remains the treatment of choice… Continue reading Transitional cell carcinoma (TCC) is the second many common urologic malignancy